Zobrazeno 1 - 10
of 524
pro vyhledávání: '"Haralampos M. Moutsopoulos"'
Autor:
Vasiliki Koulouri, Athanasios-Dimitrios Bakasis, Nikolaos Marketos, Kyriaki Tavernaraki, Mayra Giannelou, Haralampos M. Moutsopoulos, Clio P. Mavragani
Publikováno v:
Journal of Translational Autoimmunity, Vol 6, Iss , Pp 100183- (2023)
Systemic sclerosis (SSc) has been classically linked to interstitial lung disease (ILD) development, often in association with specific SSc autoantibodies. In the present report, we aimed to estimate the prevalence of SSc autoantibodies in 60 seropos
Externí odkaz:
https://doaj.org/article/c473d23386404d6e9cf1bb406a95b152
Autor:
Georgios Boutzios, Eleni Koukoulioti, Andreas V. Goules, Ioannis Kalliakmanis, Ilias Giovannopoulos, Panayiotis Vlachoyiannopoulos, Haralampos M. Moutsopoulos, Athanasios G. Tzioufas
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundHashimoto thyroiditis (HT) is an autoimmune disease which may result in extensive damage of the thyroid gland. Chronic atrophic gastritis (CAG), is the most frequent HT-associated disorder, with anti-parietal cell autoantibodies (APCA) bein
Externí odkaz:
https://doaj.org/article/1bd115ffc3e44640bf39f9163000fc46
Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
Autor:
Christina-Maria Flessa, Evangelia Zampeli, Maria-Eleftheria Evangelopoulos, Vasilis Natsis, Iris L. A. Bodewes, Erika Huijser, Marjan A. Versnel, Haralampos M. Moutsopoulos, Clio P. Mavragani
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Background/PurposePrimary Sjögren’s Syndrome (SS) is characterized by B lymphocyte hyperactivity with B cell activating factor (BAFF) acting as an important regulator. Single Nucleotide Polymorphisms (SNPs) of the BAFF gene have been implicated in
Externí odkaz:
https://doaj.org/article/15fb7d63c5604ccfbb1fe214b2e21159
Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
Autor:
Adrianos Nezos, Charalampos Skarlis, Anna Psarrou, Konstantinos Markakis, Panagiotis Garantziotis, Asimina Papanikolaou, Fotini Gravani, Michael Voulgarelis, Athanasios G. Tzioufas, Michael Koutsilieris, Haralampos M. Moutsopoulos, Eleni Kotsifaki, Clio P. Mavragani
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundB-cell non-Hodgkin’s lymphoma (B-NHL) is one of the major complications of primary Sjögren’s syndrome (SS). Chronic inflammation and macrophages in SS minor salivary glands have been previously suggested as significant predictors for l
Externí odkaz:
https://doaj.org/article/a76ab592f8a348f4aaddce5cf22d429b
Autor:
Haralampos M. Moutsopoulos
Publikováno v:
Journal of Translational Autoimmunity, Vol 4, Iss , Pp 100129- (2021)
Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one
Externí odkaz:
https://doaj.org/article/a794941b412c4a3fa15cdd29f74541ae
Autor:
Andreas V. Goules, Ourania D. Argyropoulou, Vasileios C. Pezoulas, Loukas Chatzis, Elena Critselis, Saviana Gandolfo, Francesco Ferro, Marco Binutti, Valentina Donati, Sara Zandonella Callegher, Aliki Venetsanopoulou, Evangelia Zampeli, Maria Mavrommati, Paraskevi V. Voulgari, Themis Exarchos, Clio P. Mavragani, Chiara Baldini, Fotini N. Skopouli, Dimitrios I. Fotiadis, Salvatore De Vita, Haralampos M. Moutsopoulos, Athanasios G. Tzioufas
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
ObjectivesTo study the clinical, serological and histologic features of primary Sjögren’s syndrome (pSS) patients with early (young ≤35 years) or late (old ≥65 years) onset and to explore the differential effect on lymphoma development.Methods
Externí odkaz:
https://doaj.org/article/481d5fea16b740e09ceceae1d046e364
Autor:
Charalampos Skarlis, Nikolaos Marketos, Adrianos Nezos, Asimina Papanikolaou, Michael Voulgarelis, Michael Koutsilieris, Haralampos M. Moutsopoulos, Clio P. Mavragani
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 17, p 3960 (2021)
Background: Alterations of the insulin-like growth factor (IGF) pathway along with genetic variations of the IGF1 receptor (IGF1R) gene have been linked to the development of systemic autoimmunity, possibly through apoptosis induction. This study aim
Externí odkaz:
https://doaj.org/article/d9849364229849b7822659f8ffddd0d3
Autor:
Sofia Fragkioudaki, Adrianos Nezos, Vassilis L. Souliotis, Ilenia Chatziandreou, Angelica A. Saetta, Nikolaos Drakoulis, Athanasios G. Tzioufas, Michael Voulgarelis, Petros P. Sfikakis, Michael Koutsilieris, Mary K. Crow, Haralampos M. Moutsopoulos, Clio P. Mavragani
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Primary Sjogren’s syndrome (pSS) confers increased risk for non-Hodgkin lymphoma (NHL) development. Two common polymorphisms, the c. 677C > T and c. 1298A > C, of the methylene-tetrahydrofolate reductase (MTHFR) gene, an enzyme essential i
Externí odkaz:
https://doaj.org/article/3da35a06e8ad43e58ea639c207651de5
Publikováno v:
Clinical Case Reports, Vol 8, Iss 8, Pp 1586-1587 (2020)
Abstract Respiratory complaints alone or in association with musculoskeletal complaints can be the predominant presenting feature of antisynthetase syndrome. Therefore, antibodies to cellular antigens should be evaluated in such clinical settings.
Externí odkaz:
https://doaj.org/article/063a50f5546740b896da92d92c2b6a7c
Autor:
Evangelia Argyriou, Adrianos Nezos, Petros Roussos, Aliki Venetsanopoulou, Michael Voulgarelis, Kyriaki Boki, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos, Clio P. Mavragani
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4, p 644 (2021)
Background: Primary Sjogren’s syndrome (SS) is an autoimmune disease with a strong predilection for lymphoma development, with earlier disease onset being postulated as an independent risk factor for this complication. Variations of the Leukocyte i
Externí odkaz:
https://doaj.org/article/3fb8e7561b33483daf46083e28aa6187